Search for a research project
Other search option(s)
97 Result(s)
Funded by an IRDiRC member = 
Research projects
FRANCE
ILE-DE-FRANCE
PARIS
FRANCE
ILE-DE-FRANCE
PARIS
Hereditary dystrophies of retina: physiopathologic and clinic research
Institut de la Vision
Centre d'Investigation Clinique (CIC) de l'hôpital des Quinze-Vingts
FRANCE
ILE-DE-FRANCE
PARIS
Hereditary dystrophies of retina: pharmacological research and new therapeutics development (cell and gene therapies)
Institut de la Vision
Centre d'Investigation Clinique (CIC) de l'hôpital des Quinze-Vingts
FRANCE
ILE-DE-FRANCE
PARIS
Preclinical validation of a stem cell-derived Retinal Pigmented Epithelium (RPE) in non-human primates
Institut de la Vision
Centre de Recherche Institut de la Vision
FRANCE
ILE-DE-FRANCE
PARIS
eyePS: Modeling and treatment of retinal dystophies with iPS cells - FR
Institut de la Vision
Centre de Recherche Institut de la Vision
FRANCE
OCCITANIE
MONTPELLIER
Genetics of autosomal recessive retinitis pigmentosa and of macular dystrophies
Hôpital Saint Eloi - Bâtiment INM
Equipe "Génétique et thérapie des cécités rétiniennes et du nerf optique"
FRANCE
OCCITANIE
MONTPELLIER
Dominant autosomic retinitis pigmentosa: prevalence of known genes and identification of new ones
Hôpital Saint Eloi - Bâtiment INM
Equipe "Génétique et thérapie des cécités rétiniennes et du nerf optique"
FRANCE
PAYS DE LA LOIRE
NANTES
Evaluation of the immune response in Briards dogs RPE65 -/- treated with gene therapy
CHU de Nantes - Hôtel Dieu
Vecteurs viraux et transfert de genes in vivo
GERMANY
Baden-Württemberg
TÜBINGEN
Rate of Progression in USH2A Related Retinal Degeneration
Department für Augenheilkunde Tübingen
Universitäts-Augenklinik
ITALY
EMILIA ROMAGNA
MODENA
Exploring PEDF as therapeutic agent for retinitis pigmentosa
Università degli Studi di Modena e Reggio Emilia
Laboratorio Eye Diseases
ITALY
LAZIO
ROMA
Understanding molecular basis for Inherited Retinal Diseases (IRDs)
ISS - Istituto Superiore di Sanità
Centro Nazionale per la Ricerca e la Valutazione preclinica e clinica dei Farmaci
ITALY
LIGURIA
GENOVA
Development and application of optoneural prosthetic devices as a therapeutic approach for Retinitis pigmentosa
IRCCS AOU San Martino - IST - DIMI
Dipartimento di Medicina Sperimentale
ITALY
TOSCANA
PISA
Integrate analysis of the cellular and molecular processes responsible for the elaboration of sensory signals in normal and pathological conditions.
Università degli Studi di Pisa
Dipartimento di Farmacia
JAPAN
JAPAN
ADDRESS : NOT PROVIDED - JP
Omics analysis to identify disease-causing mutation and molecular
Institution: Information not provided - JP
JAPAN
JAPAN
ADDRESS : NOT PROVIDED - JP
Manufacture and quality control, first-in-human feasibility study as investigator
Institution: Information not provided - JP
JAPAN
JAPAN
MIYAGI
Intensive genetic analysis and elucidation of the pathology by genome editing aiming at gene-specific treatment for retinitis pigmentosa
Tohoku University Graduate School of Medicine
Department of Advanced Ophthalmic Medicine
NETHERLANDS
Gelderland
NIJMEGEN
Identification of the genetic causes of inherited retinal dystrophies
Radboudumc - Radboud universitair medisch centrum
Afdeling Genetica
NETHERLANDS
Gelderland
NIJMEGEN
Identification of the genetic causes of inherited retinal dystrophies
Radboudumc - Radboud universitair medisch centrum
Afdeling Oogheelkunde
SPAIN
Andalucía
SEVILLA
Mathematical models of disease mechanisms to reformulate drugs for rare diseases
Fundación Progreso y Salud
Área de bioinformática clínica
SPAIN
Comunidad Valenciana
VALENCIA
Development of anti-inflammatory nanotherapies for retinitis pigmentosa
IIS La Fe - Instituto de Investigación Sanitaria La Fe
Grupo de investigación en biomedicina molecular, celular y genómica
SWEDEN
Skane
LUND
Retinal transplantation: strategies for clinical therapy of Retinitis pigmentosa
Lund University
Division of Ophthalmology
SWEDEN
Stockholms läns landsting
STOCKHOLM
Genetic and molecular mechanisms in familial visual impairment
Karolinska Institutet - Solna
Department of molecular medicine and surgery
UNITED KINGDOM
Greater Manchester
ADDRESS: NOT PROVIDED - UK
Prolonging vision in retinitis pigmentosa by AAV-mediated genetic modulation of the insulin/AKT/mTOR pathway
Institution: Information not provided - UK
UNITED STATES
California
BERKELEY
Function of ciliary disease protein retinitis pigmentosa gtpase regulator (rpgr)
University Of California Berkeley
Ophthalmology
UNITED STATES
South Carolina
COLUMBIA
Rate of Progression in USH2A Related Retinal Degeneration
Foundation Fighting Blindness
Foundation Fighting Blindness USA
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Preclinical innovation
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Drug repurposing screening for rare and neglected diseases
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Drug discovery and mechanistic study of p23h rhodopsin associated retinitis pigmentosa
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Gene silencing and gene editing in phototransduction
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Modeling photoreceptor development and disease using human pluripotent stem cells
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Dhdds and retinal degeneration
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Large animal therapy studies
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Human connectomes for low vision; blindness; and sight restoration
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Broad-band opsin and targeted optical-delivery for retinitis pigmentosa treatment
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Cone rescue in retinitis pigmentosa
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Crumbs proteins for photoreceptor development and health maintenance
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Development of allele independent gene therapy strategies for autosomal dominant retinitis pigmentsa
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Mechanism of death of bystander retinal cells during mcmv infection
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Mechanistic studies on regenerative medicine approaches to childhood blindness
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Nanoparticle-based therapy for photoreceptor degeneration
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Neuroprotective mechanisms of inosine monophosphate dehydrogenase inhibitors in retinitis pigmentosa
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Novel imaging of rod oxidative stress in retinal disease and treatment in vivo
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Targeting retinitis pigmentosa using nanoparticle-mediated delivery of genomic dna
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Crispr/cas9 gene editing to rescue vision in rodent model for autosomal dominant retinitis pigmentosa
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Function of c8orf37 in photoreceptors
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Genetic modifiers of retinal disease
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Imaging the functional biomarker of photoreceptors
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Modulation of lipid bisretinoids clearance with beta-cyclodextrins
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Noninvasive assessment of pathophysiology in retinitis pigmentosa
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Retinal tissue derived from human pluripotent stem cells for vision restoration
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Role of microglia in retinitis pigementosa
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
The role of arap1 in retinal photoreceptor homeostasis
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Color vision in inherited retinal degenerations
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Disease mechanism and therapies for retinal degeneration
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Genomic analysis in genes responsible for eye abnormalities in patients
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Human rhodopsin-adrp studies
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Inherited ocular diseases
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Interventional approaches for restoring vision
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Mechanisms of retinal degeneration in inherited diseases
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
National ophthalmic disease genotyping and phenotyping network - eyegene
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
The focal electro-oculogram in macular disease
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Retinal gene therapy
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Preclinical safety studies
Institution: Information not provided - US
FRANCE
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
Developing and studying the effects of innovative therapies for rare inherited retinal disease using human retinal models derived from patient iPS cells
Institution: Information not provided - FR
FRANCE
AUVERGNE-RHONE-ALPES
LYON
DIVERCIL: Understanding cilia and flagella diversity - FR
Faculté de Médecine Lyon Est
Institut NeuroMyoGène (INMG) - CNRS UMR 5310 / INSERM U1217
FRANCE
GRAND-EST
STRASBOURG
Retinis Pigmentosa: validation of the molecular diagnostic using next generation sequencing
CHU de Strasbourg - Hôpital Civil
Laboratoire de diagnostic génétique
FRANCE
ILE-DE-FRANCE
PARIS
Epidemiological study in hereditary dystrophies of retina
Institut de la Vision
Centre d'Investigation Clinique (CIC) de l'hôpital des Quinze-Vingts
FRANCE
ILE-DE-FRANCE
PARIS
Comprehensive genetic analysis of inherited retinal disease applying highthroughput next generation sequencing
Institut de la Vision
Centre de Recherche Institut de la Vision
FRANCE
OCCITANIE
MONTPELLIER
Gene therapy of retinal dystrophy on human models: differentiation of patients iPS cells to retinal cells
Hôpital Saint Eloi - Bâtiment INM
Equipe "Génétique et thérapie des cécités rétiniennes et du nerf optique"
SPAIN
Madrid
MADRID
Genomics, preclinical and clinical studies as tools for personalized medicine in retinal dystrophies
Fundación Jiménez Díaz
Área de Genética y Genómica
UNITED KINGDOM
Cambridgeshire
CAMBRIDGE
Active BRIDGE Studies - Specialist Pathology: Evaluating Exomes in Diagnostics (SPEED)
Wellcome Trust/MRC Building
Cambridge Institute for Medical Research
FRANCE
ILE-DE-FRANCE
PARIS
STaHR : Stimulation of Targeted Homologous Recombination for Gene Therapy - FR
Muséum National d'Histoire Naturelle
Laboratoire Structure et Instabilité des Génomes - INSERM U1154 - CNRS 7196
FRANCE
PAYS DE LA LOIRE
NANTES
FROGH : FRench Regional Origins in Genetics for Health - FR
Institut de Recherche en Santé - Université de Nantes
L'Institut du thorax - Inserm UMR 1087 / CNRS UMR 6291
GERMANY
Hessen
GIEßEN
Barrier free chromatic pupillometry in children from infancy on. A novel biomarker to quantify outer and inner retinal function in inherited retinal disorders as a measure of therapeutic benefit after gene therapy (SPP 2127: Gene and cell based therapies to counteract neuroretinal degeneration)
Augenklinik des UKGM am Standort Gießen
Klinik und Poliklinik für Augenheilkunde
ITALY
CAMPANIA
NAPOLI
Telethon Undiagnosed Disease Program - Revised Proposal
TIGEM - Telethon Institute of Genetics and Medicine
Genomic Medicine - Telethon Institute of Genetics and Medicine
JAPAN
JAPAN
AICHI
Management ofthe clinical diagnostic centre for rare intractable diseases with genome instability and development of potential therapeutic medicine
Research Institute of Environmental Medicine, Nagoya University
JAPAN
JAPAN
AICHI
Establishment of the Next-generation Muti-omics Clinical Diagnostic Centre for rare intractable diseases with genome instability
Research Institute of Environmental Medicine, Nagoya University
JAPAN
JAPAN
TOKYO
Formation of integrated omics analysis base of refractory diseases in children and perinatal period
National Center for Child Health and Development
Research Institute
SPAIN
Madrid
MADRID
An integrated analysis system to increase the rate of diagnosis of rare diseases using massive sequencing
Fundación Jiménez Díaz
Área de Genética y Genómica
Multicentric Research projects
- GENOPOLE - Campus 1
- I-Stem - Institut des cellules Souches pour le Traitement et l'Etude des maladies Monogéniques
- Centre hospitalier national d'ophtalmologie des Quinze-Vingts
- Centre de Référence REFERET
- Institut de la Vision
- Centre d'Investigation Clinique (CIC) de l'hôpital des Quinze-Vingts
- Institut de la Vision
- Centre de Recherche Institut de la Vision
- Université Pierre et Marie Curie - Paris 6
- Département Traitement des Informations Visuelles
- Department für Augenheilkunde Tübingen
- Molekulargenetisches Labor
- Department für Augenheilkunde Tübingen
- Forschungsinstitut für Augenheilkunde
- TIGEM - Telethon Institute of Genetics and Medicine
- Laboratorio di Ricerca
- Radboudumc - Radboud universitair medisch centrum
- Afdeling Genetica
- Faculté de Médecine Lyon Est
- Institut NeuroMyoGène (INMG) - CNRS UMR 5310 / INSERM U1217
- Institut de la Vision
- Centre d'Investigation Clinique (CIC) de l'hôpital des Quinze-Vingts
- Hospital Universitario Fundación Jiménez Díaz
- Servicio de Genética Clínica
- University of British Columbia
- Maternal Infant Child and Youth Research Network
- Muséum National d'Histoire Naturelle
- Laboratoire Structure et Instabilité des Génomes - INSERM U1154 - CNRS 7196
- Institut de Recherche en Santé - Université de Nantes
- L'Institut du thorax - Inserm UMR 1087 / CNRS UMR 6291
- Department für Augenheilkunde Tübingen
- Forschungsinstitut für Augenheilkunde
- IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO
- Servizio Clinico di Consulenza Genetica
- EEIG - EUROPEAN VISION INSTITUTE
- EUROPEAN VISION INSTITUTE
FRANCE
ILE-DE-FRANCE
EVRY
SightREPAIR: Preclinical validation of a stem cell-derived retinal pigmented epithelium for treatment of retinal degenerative diseases
FRANCE
ILE-DE-FRANCE
PARIS
RHORCOD: comprehensive analysis of rod-cone photoreceptor degeneration associated with Rhodopsin gene mutations
FRANCE
ILE-DE-FRANCE
PARIS
RDCVF: rod-derived cone viability factor (TERMINATED)
FRANCE
ILE-DE-FRANCE
PARIS
eyePS: Modeling and treatment of retinal dystophies with iPS cells
FRANCE
ILE-DE-FRANCE
PARIS
OPTOREMODE: Retinitis Pigmentosa diagnosis and therapy: retinal remodeling and optogenetic reactivation of degenerated retina
GERMANY
Baden-Württemberg
TÜBINGEN
RETNET: European Retinal Research Training Network
GERMANY
Baden-Württemberg
TÜBINGEN
DRUGSFORD: Preclinical development of drugs and drug delivery technology for the treatment of inherited photoreceptor degeneration
ITALY
CAMPANIA
NAPOLI
AAVEYE: gene therapy for inherited severe photoreceptor diseases
NETHERLANDS
Gelderland
NIJMEGEN
SYSCILIA: A systems biology approach to dissect cilia function and its disruption in human genetic disease
FRANCE
AUVERGNE-RHONE-ALPES
LYON
DIVERCIL: Understanding cilia and flagella diversity
FRANCE
ILE-DE-FRANCE
PARIS
EVI-GENORET: functional genomics of the retina in health and disease (FINISHED)
SPAIN
Madrid
MADRID
EsRetNet: Spanish Network of Reseach on Retinal Dystrophies
CANADA
Colombie-Britannique
VANCOUVER
Maternal Infant Child and Youth Research Network (MICYRN)
FRANCE
ILE-DE-FRANCE
PARIS
STaHR : Stimulation of Targeted Homologous Recombination for Gene Therapy
FRANCE
PAYS DE LA LOIRE
NANTES
FROGH : FRench Regional Origins in Genetics for Health
GERMANY
Baden-Württemberg
TÜBINGEN
HOPE 2: Hereditary Retinal Disorders - From Patients Towards Therapies
ITALY
LAZIO
ROMA
UnRareNet: a muticenter collaborative research network for the identification and study of rare undiagnosed patients (completed)
BELGIUM
ARRONDISSEMENT BRUSSELS-CAPITAL
BRUXELLES